Early lung damage patterns uncovered in children with cystic fibrosis
Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights…
Colbopasvir plus sofosbuvir achieves high cure rates in chronic hepatitis C
Abstract In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) +…
Air pollution linked to rising kidney disease hospitalization risks
A study supported by FAPESP and published in the journal Scientific Reports showed a strong correlation between the concentration of…
New AI Blood Test Detects Silent Liver Disease Before Symptoms Appear
Researchers at Johns Hopkins have created an AI-powered blood test that may uncover silent liver disease years before…
Biliary epithelial cells found to actively prevent liver fibrosis development
Many liver diseases share a common characteristic: fibrosis, that is, the progressive accumulation of scarring in the liver…
New mechanism disables antibiotic resistance and cross-protection in bacteria
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known…
Immune cell interactions drive liver inflammation and fibrosis
When the liver is injured – for example, due to bile accumulation – immune cells become activated. In…
Gut-liver changes drive foodborne infection severity in fatty liver disease
A research team led by the University of California, Irvine’s Joe C. Wen School of Population & Public…
Toxic RNA drives progressive heart damage in myotonic dystrophy
Myotonic dystrophy type 1 (DM1) is the most common cause of adult-onset muscular dystrophy, a genetic disorder that…
EVA1A regulates fatty acid transporter CD36 in fatty liver disease
Metabolic Dysfunction-Associated Steatotic Liver Disease（MASLD） is characterized by excessive accumulation of lipids in hepatocytes and is closely associated…
New fragmentome technology can detect early liver fibrosis and cirrhosis
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free…
How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…